The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Both v-Ha-Ras and v-Raf Stimulate Expression of the Vascular Endothelial Growth Factor in NIH 3T3 Cells
Open accessAbstract
Stimulation of NIH 3T3 cells with platelet-derived growth factor (PDGF)-BB and 12-O-tetradecanoylphorbol-13-acetate (TPA) enhances vascular endothelial growth factor (VEGF) gene expression. To address the question of whether Ras and Raf are involved in the induction of VEGF gene expression by PDGF and TPA, we examined the effects of both factors on NIH 3T3 cells stably transfected with v-Ha-ras or v-raf. In serum-starved NIH 3T3 cells, only low levels of mRNA expression can be detected, whereas both ras and raf transformed cell lines express enhanced levels of a 4.3-kilobase VEGF transcript. Stimulation with PDGF or TPA resulted in increased VEGF mRNA in all cell lines, with highest levels found in the transformed cells. Immunofluorescence studies confirmed that the elevated VEGF mRNA expression correlated with enhanced protein levels. Positive immunofluorescence signals could be detected in v-Ha-ras or v-raf transformed cell lines but not in unstimulated NIH 3T3 cells. VEGF from conditioned medium of v-raf transformed NIH 3T3 cells was partially purified by chromatography on heparin-Sepharose. Biological activity of this VEGF protein was demonstrated by competition with binding of recombinant 125I-VEGF165 to human umbilical vein endothelial cells and by its ability to stimulate proliferation of these cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Barbacid, M. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.004023 · Cited by 3,885
Ferrara, N., & Henzel, W. J. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92678-8 · Cited by 2,268
Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
Almoguera, C., Shibata, D., Forrester, K., Martin, J., Arnheim, N., & Perucho, M. (1988) · Cell · doi:10.1016/0092-8674(88)90571-5 · Cited by 2,114
Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C., & Abraham, J. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99049-6 · Cited by 1,476
Phosphorylation of c-jun mediated by MAP kinases
Pulverer, B. J., Kyriakis, J. M., Avruch, J., Nikolakaki, E., & Woodgett, J. R. (1991) · Nature · doi:10.1038/353670a0 · Cited by 1,468
Houck, K. A., Ferrara, N., Winer, J., Cachianes, G., Li, B., & Leung, D. W. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-12-1806 · Cited by 1,365
Raf-1 activates MAP kinase-kinase
Kyriakis, J. M., App, H., Zhang, X.-F., Banerjee, P., Brautigan, D. L., Rapp, U. R., & Avruch, J. (1992) · Nature · doi:10.1038/358417a0 · Cited by 1,283
Protein kinase Cα activates RAF-1 by direct phosphorylation
Kolch, W., Heidecker, G., Kochs, G., Hummel, R., Vahidi, H., Mischak, H., Finkenzeller, G., Marmé, D., & Rapp, U. R. (1993) · Nature · doi:10.1038/364249a0 · Cited by 1,277
Self-citationDetection of high incidence of K-ras oncogenes during human colon tumorigenesis
Forrester, K., Almoguera, C., Han, K., Grizzle, W. E., & Perucho, M. (1987) · Nature · doi:10.1038/327298a0 · Cited by 1,061
Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells
Mulcahy, L. S., Smith, M. R., & Stacey, D. W. (1985) · Nature · doi:10.1038/313241a0 · Cited by 878
Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1
Zhang, X.-F., Settleman, J., Kyriakis, J., Takeuchi-Suzuki, E., Elledge, S. J., Marshall, M. S., Bruder, J. T., Rapp, U. R., & Avruch, J. (1993) · Nature · doi:10.1038/364308a0 · Cited by 858
Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro
Warne, P. H., Vician, P. R., & Downward, J. (1993) · Nature · doi:10.1038/364352a0 · Cited by 712
Senger, D. R., Perruzzi, C. A., Feder, J., & Dvorak, H. F. (1986) · PubMed · Cited by 646
The vascular endothelial growth factor family of polypeptides
Ferrara, N., Houck, K. A., Jakeman, L. B., Winer, J., & Leung, D. W. (1991) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240470305 · Cited by 641
Gospodarowicz, D., Abraham, J. A., & Schilling, J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7311 · Cited by 559
Wasylyk, B., Wasylyk, C., Flores, P., Begue, A., Leprince, D., & Stehelin, D. (1990) · Nature · doi:10.1038/346191a0 · Cited by 496
Structure and biological activity of v-raf, a unique oncogene transduced by a retrovirus.
Rapp, U. R., Goldsborough, M. D., Mark, G. E., Bonner, T. I., Groffen, J., Reynolds, F. H., & Stephenson, J. R. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.14.4218 · Cited by 483
Serum-, TPA-, and Ras-induced expression from Ap-1/Ets-driven promoters requires Raf-1 kinase.
Bruder, J. T., Heidecker, G., & Rapp, U. R. (1992) · Genes & Development · doi:10.1101/gad.6.4.545 · Cited by 444
Vascular permeability factor: A unique regulator of blood vessel function
Connolly, D. T. (1991) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240470306 · Cited by 317
Vascular Endothelial Growth Factor is Expressed in Rat Corpus Luteum
PHILLIPS, H. S., HAINS, J., LEUNG, D. W., & FERRARA, N. (1990) · Endocrinology · doi:10.1210/endo-127-2-965 · Cited by 277
Satoh, T., Endo, M., Nakafuku, M., Akiyama, T., Yamamoto, T., & Kaziro, Y. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.20.7926 · Cited by 257
A Harvey-ras responsive transcription element is also responsive to a tumour-promoter and to serum
Imler, J. L., Schatz, C., Wasylyk, C., Chatton, B., & Wasylyk, B. (1988) · Nature · doi:10.1038/332275a0 · Cited by 182
AIDS-associated kaposi's sarcoma cells in culture express vascular endothelial growth factor
Weindel, K., Marmé, D., & Weich, H. A. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80313-4 · Cited by 161
Self-citationSuppression of c-ras transformation by GTPase-activating protein
Zhang, K., DeClue, J. E., Vass, W. C., Papageorge, A. G., McCormick, F. P., & Lowy, D. R. (1990) · Nature · doi:10.1038/346754a0 · Cited by 157
Aortic Smooth Muscle Cells Express and Secrete Vascular Endothelial Growth Factor
Ferrara, N., Winer, J., & Burton, T. (1991) · Growth Factors · doi:10.3109/08977199109000278 · Cited by 144
Jamal, S., & Ziff, E. B. (1990) · Nature · doi:10.1038/344463a0 · Cited by 129
Conditioned Medium from Mouse Sarcoma 180 Cells Contains Vascular Endothelial Growth Factor
Rosenthal, R. A., Megyesi, J. F., Henzel, W. J., Ferrara, N., & Folkman, J. (1990) · Growth Factors · doi:10.3109/08977199009011010 · Cited by 100
Raf-1 and p21v-ras cooperate in the activation of mitogen-activated protein kinase.
Williams, N. G., Paradis, H., Agarwal, S., Charest, D. L., Pelech, S., & Roberts, T. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5772 · Cited by 96
v-Src activates mitogen-responsive transcription factor Egr-1 via serum response elements
Qureshi, S. A., Cao, X., Sukhatme, V. P., & Foster, D. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99089-7 · Cited by 95
Stephens, R. M., Sithanandam, G., Copeland, T. D., Kaplan, D. R., Rapp, U. R., & Morrison, D. K. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.9.3733-3742.1992 · Cited by 88
Kaibuchi, K., Fukumoto, Y., Oku, N., Hori, Y., Yamamoto, T., Toyoshima, K., & Takai, Y. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)30013-4 · Cited by 66
The phosphorylation and activation of B-raf in PC12 cells stimulated by nerve growth factor.
Oshima, M., Sithanandam, G., Rapp, U. R., & Guroff, G. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54347-7 · Cited by 66
Cell-specific regulation of oncogene-responsive sequences of the c-fos promoter.
Gutman, A., Wasylyk, C., & Wasylyk, B. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.10.5381 · Cited by 62
Oncogene activation: c-raf-1 gene mutations in experimental and naturally occurring tumors
Storm, S. M., & Rapp, U. R. (1993) · Toxicology Letters · doi:10.1016/0378-4274(93)90056-4 · Cited by 53
Cited by
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591
The Biology of Vascular Endothelial Growth Factor
Ferrara, N., & Davis-Smyth, T. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0287 · Cited by 4,330
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
Ferrara, N. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0027 · Cited by 3,687
Vascular endothelial growth factor (VEGF) and its receptors
NEUFELD, G., COHEN, T., GENGRINOVITCH, S., & POLTORAK, Z. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.1.9 · Cited by 3,483
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
Ferrara, N., Hillan, K. J., Gerber, H.-P., & Novotny, W. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1381 · Cited by 2,625
“Oncogenic mutations or amplification of RAS lead to VEGF upregulatio”
Background
Metadata
- Authors
- Grugel, S., Finkenzeller, G., Weindel, K., Barleon, B., & Marmé, D.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1995-10
- Volume
- 270
- Issue
- 43
- Pages
- 25915-25919
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2019273955
- Cited by
- 329
- References
- 38
- FWCI
- 5.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.